Related Experiment Videos
[Experiences with hemangiopericytoma in cranial base surgery]
1Klinik für HNO-Krankheiten, Kopf-, Hals- und Plastische Gesichtschirurgie, Kommunikationsstörungen, Städtisches Klinikum Fulda.
Laryngo- Rhino- Otologie
|June 30, 1998
Summary
Haemangiopericytomas, rare vascular tumors, can aggressively recur in the head and neck, necessitating lifelong monitoring and complete surgical removal for optimal outcomes.
Area of Science:
- Oncology
- Vascular Neoplasms
- Skull Base Surgery
Background:
- Haemangiopericytomas are rare vascular tumors with unpredictable growth, recurrence, and metastasis potential.
- Prognostic indicators for haemangiopericytomas, particularly in the head and neck, remain uncertain.
- Clinical course is often the primary determinant of haemangiopericytoma behavior.
Observation:
- Five cases of haemangiopericytoma involving the skull base were analyzed out of 457 total skull base tumors.
- Tumor origins included nasal septum, pterygopalatine fossa, oronasopharynx, temporal bone, and parotid gland.
- Two cases demonstrated intracranial extension, and three patients experienced multiple surgical recurrences.
Findings:
- Head and neck haemangiopericytomas exhibit a potential for malignant behavior and late recurrences.
- One patient experienced five recurrences despite multiple surgical interventions.
- Aggressive tumor progression and recurrence underscore the challenges in managing these neoplasms.
Implications:
- Complete surgical resection is the recommended treatment for haemangiopericytomas, despite technical difficulties.
- Lifelong follow-up is crucial due to the high recurrence rate, even decades later.
- Early and consistent management is vital for improving patient outcomes with haemangiopericytomas.